Through the 3-D Tissue Bioprinting program, NCATS collaborates with academic investigators in the basic and clinical research communities who provide disease and cell biology expertise and materials. NCATS also works with private-sector partners, such as Organovo, to access technology and engineering solutions.
NCATS is interested in establishing new collaborations with pharmaceutical and biotechnology companies. These efforts would focus on benchmarking and establishing translational capacity for tissue-in-a-well assays to be integrated into the discovery and development process for new therapies.
Contact Marc Ferrer or Sam Michael if you are interested in working with the NCATS 3-D Tissue Bioprinting team.